chr13-67225758-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_203487.3(PCDH9):c.2683G>A(p.Ala895Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000734 in 1,614,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 0 hom. )
Consequence
PCDH9
NM_203487.3 missense
NM_203487.3 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 3.68
Genes affected
PCDH9 (HGNC:8661): (protocadherin 9) This gene encodes a member of the protocadherin family, and cadherin superfamily, of transmembrane proteins containing cadherin domains. These proteins mediate cell adhesion in neural tissues in the presence of calcium. The encoded protein may be involved in signaling at neuronal synaptic junctions. Sharing a characteristic with other protocadherin genes, this gene has a notably large exon that encodes multiple cadherin domains and a transmembrane region. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Nov 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.035706133).
BS2
High AC in GnomAd4 at 50 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PCDH9 | NM_203487.3 | c.2683G>A | p.Ala895Thr | missense_variant | 2/5 | ENST00000377865.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PCDH9 | ENST00000377865.7 | c.2683G>A | p.Ala895Thr | missense_variant | 2/5 | 1 | NM_203487.3 | ||
PCDH9 | ENST00000544246.5 | c.2683G>A | p.Ala895Thr | missense_variant | 2/4 | 1 | P1 | ||
PCDH9 | ENST00000456367.5 | c.2683G>A | p.Ala895Thr | missense_variant | 2/5 | 1 | |||
PCDH9 | ENST00000377861.4 | c.2683G>A | p.Ala895Thr | missense_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152190Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
50
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000354 AC: 89AN: 251460Hom.: 0 AF XY: 0.000346 AC XY: 47AN XY: 135898
GnomAD3 exomes
AF:
AC:
89
AN:
251460
Hom.:
AF XY:
AC XY:
47
AN XY:
135898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000776 AC: 1135AN: 1461746Hom.: 0 Cov.: 33 AF XY: 0.000729 AC XY: 530AN XY: 727186
GnomAD4 exome
AF:
AC:
1135
AN:
1461746
Hom.:
Cov.:
33
AF XY:
AC XY:
530
AN XY:
727186
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000328 AC: 50AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74482
GnomAD4 genome
AF:
AC:
50
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
21
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
6
ExAC
AF:
AC:
40
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | The c.2683G>A (p.A895T) alteration is located in exon 2 (coding exon 1) of the PCDH9 gene. This alteration results from a G to A substitution at nucleotide position 2683, causing the alanine (A) at amino acid position 895 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.;.
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T
Sift4G
Benign
T;T;T;T
Polyphen
B;B;B;P
Vest4
MVP
MPC
0.29
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at